Z

Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077

Watchlist Manager
Zhejiang Huakang Pharmaceutical Co Ltd
SSE:605077
Watchlist
Price: 15.27 CNY 0.2% Market Closed
Market Cap: ¥4.6B

Wall Street
Price Targets

Price Targets Summary
Zhejiang Huakang Pharmaceutical Co Ltd

There are no price targets for Zhejiang Huakang Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Zhejiang Huakang Pharmaceutical Co Ltd Competitors:
Price Targets

Revenue
Forecast

12% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
12% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

For the last 6 years the compound annual growth rate for Zhejiang Huakang Pharmaceutical Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 33%.

Operating Income
Forecast

5% / Year
Past Growth
35% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
5% / Year
Past Growth
35% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 6 years the compound annual growth rate for Zhejiang Huakang Pharmaceutical Co Ltd's operating income is 5%. The projected CAGR for the next 3 years is 35%.

Net Income
Forecast

5% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
5% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 6 years the compound annual growth rate for Zhejiang Huakang Pharmaceutical Co Ltd's net income is 5%. The projected CAGR for the next 3 years is 30%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang Huakang Pharmaceutical Co Ltd's stock price target?
Not Available

Zhejiang Huakang Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Zhejiang Huakang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
33%

For the last 6 years the compound annual growth rate for Zhejiang Huakang Pharmaceutical Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 33%.

What is Zhejiang Huakang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
35%

For the last 6 years the compound annual growth rate for Zhejiang Huakang Pharmaceutical Co Ltd's operating income is 5%. The projected CAGR for the next 3 years is 35%.

What is Zhejiang Huakang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
30%

For the last 6 years the compound annual growth rate for Zhejiang Huakang Pharmaceutical Co Ltd's net income is 5%. The projected CAGR for the next 3 years is 30%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett